Bibliography
- Abdool Karim Q , Abdool KarimSS, FrohlichJAet al.: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science3, 329(5996), 1168–1174(2010).
- McCormack S , RamjeeG, KamaliAet al.: PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a Phase 3, randomised, double-blind, parallel-group trial.Lancet16, 376(9749), 1329–1337(2010).
- Abdool Karim SS , ColettiA, RichardsonBet al.: Safety and effectiveness of vaginal microbicides buffer gel and 0.5% PRO 2000/5 gel for the prevention of HIV infection in women: results of the HPTN 035 trial. Presented at: 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada, 8–11 February 2009.
- Skoler-Karpoff S , RamjeeG, AhmedKet al.: Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.Lancet6, 372(9654), 1977–1987(2008).
- Feldblum PJ , AdeigaA, BakareRet al.: SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.PloS ONE3(1), E1474 (2008).
- Pool R , MontgomeryCM, MorarNSet al.: A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme.PLoS ONE23, 3(1), E1474 (2008).
- Pool R , MontgomeryCM, MorarNSet al.: Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model.PLoS One5(7), E11632 (2010).
- Check E : HIV trial doomed by design, say critics.Nature12, 448(7150), 110–111(2007).
- Schwartz J , KashubaA, RezkNet al.: Preliminary results from a pharmacokinetic study of the candidate vaginal microbicide agent 1% tenofovir gel. Presented at: Microbicides 2008. New Delhi, India, 24–27 February 2008 (Abstract BO11–61).
- Parikh UM , DobardC, SharmaSet al.: Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine.J. Virol.83(20), 10358–10365(2009).
- Dobard CW , SharmaS, HolderAet al.: Protection by TFV gel against vaginal SHIV infection in macaques three days after gel application and its relationship to tissue drug levels. Presented at: 5th International Workshop on HIV Transmission. Vienna, Austria, 15–16 July 2010.
- Grant R , LamaJ, AndersonPet al.: Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.N. Engl. J. Med. doi: 10.1056/NEJMoa1011205 (2010) (Epub ahead of print).